Pub Date : 2024-07-03DOI: 10.2174/0122115560288779240628043307
Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij M Satodiya, Rashmi Shukla, S. El Hayek
Following clinical trials on psilocybin for the treatment of pain, anxiety, and depression in patients with cancer, scientific interest emerged in its use for substance use disorders. In this review of the literature, we summarize available trials looking at the use of psilocybin in addiction One double-blind, randomized clinical trial looked at the effect of psilocybin on heavy drinking in adults diagnosed with alcohol dependence. Several trials are currently ongoing to assess psilocybin’s efficacy in the management of different SUDs. Otherwise, the current evidence is insufficient to derive any conclusions on the possible efficacy of psilocybin in substance use disorders. More well-powered, blinded, randomized controlled trials are needed to investigate the possible therapeutic effects of psilocybin in addiction while identifying the appropriate conditions that promote its safe use.
{"title":"Psilocybin in the Management of Substance Use Disorders: A Summary of\u0000Current Evidence","authors":"Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij M Satodiya, Rashmi Shukla, S. El Hayek","doi":"10.2174/0122115560288779240628043307","DOIUrl":"https://doi.org/10.2174/0122115560288779240628043307","url":null,"abstract":"\u0000\u0000Following clinical trials on psilocybin for the treatment of pain, anxiety,\u0000and depression in patients with cancer, scientific interest emerged in its use for substance use disorders.\u0000\u0000\u0000\u0000In this review of the literature, we summarize available trials looking at the use of psilocybin in addiction\u0000\u0000\u0000\u0000One double-blind, randomized clinical trial looked at the effect of psilocybin on heavy\u0000drinking in adults diagnosed with alcohol dependence. Several trials are currently ongoing to assess\u0000psilocybin’s efficacy in the management of different SUDs. Otherwise, the current evidence is insufficient to derive any conclusions on the possible efficacy of psilocybin in substance use disorders.\u0000\u0000\u0000\u0000More well-powered, blinded, randomized controlled trials are needed to investigate\u0000the possible therapeutic effects of psilocybin in addiction while identifying the appropriate conditions that promote its safe use.\u0000","PeriodicalId":10751,"journal":{"name":"Current Psychopharmacology","volume":"22 s43","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141683743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}